Board of Directors
Company Risk
The number of patients decreased, resulting in a decrease in revenue.
The hospital focuses on continuously improving the quality of medical services, while also investing in modern and safe medical instruments and equipment to elevate healthcare standards at appropriate prices for service recipients. Furthermore, Ramkhamhaeng Hospital has developed and elevated the treatment of complex diseases through the establishment of Centers of Excellence, such as the Heart Center, Brain and Neuroscience Center, and Radiotherapy Center, to accommodate the treatment of patients with complex conditions, including those referred from network hospitals. Moreover, the Company is able to provide services to various patient groups, including self-paying patients, patients under social security rights, and patients under the universal healthcare scheme. This increases opportunities for patients to access medical services and is a crucial component that helps diversify revenue sources and strengthen the revenue structure of the Ramkhamhaeng Hospital Group, thereby supporting its competitiveness and sustainable growth.
Being sued results in damage to image and reputation.
Emphasize the development of personnel potential to possess knowledge, understanding, and strictly adhere to established professional standards and work processes, in order to enhance service quality and mitigate operational risks.
-
However, the Group believes that the social security system possesses fund stability and a robust disbursement mechanism. While there may be adjustments to medical expense disbursement policies, these are implemented to align with the actual increase in medical costs. Furthermore, the Group's management closely monitors the policies of the social security scheme and continuously tracks the procedures and criteria for medical expense disbursement with the Social Security Office. This ensures that all disbursements are accurate and complete in accordance with the Office's conditions and allows for the control of relevant medical costs, thereby mitigating potential risks that could affect the Group's operational performance.
may violate relevant regulations and laws, and be subject to legal action
The Company has implemented and complied with various important quality system standards, such as the international standard ACCI (American Accreditation Commission International), JCI (Joint Commission International), the Hospital and Healthcare Services Standard HA (Hospital Accreditation) of the Ministry of Public Health, and ISO9001:2015. These standards require the Company to operate and comply with established guidelines to control the quality of patient care, oversee safety and environmental aspects, and manage various risks, which may help mitigate potential impacts arising from changes in relevant regulations or laws.
The hospital may be required to pay compensation for damages, or its reputation could be adversely affected in the future.
The Company and its subsidiaries have certain lawsuits related to business operations, which are currently under judicial review. However, management believes that such cases do not have a significant impact on the Company's financial position and operating results. Details of the lawsuits can be further reviewed in the notes to the financial statements regarding lawsuits and legal disputes.
may lead to the risk of not receiving full payment for medical expenses.
The Company therefore has a management policy to mitigate various risks, including requiring the Medical Records Department to thoroughly inquire about and verify the eligibility of service users; informing the party responsible for expenses of estimated medical costs in advance; notifying the treatment plan and reporting incurred expenses along with periodic advance cost estimations; and proposing that the party responsible for medical expenses make installment payments to reduce risk and alleviate the burden of paying the full amount upon completion of treatment. Regarding the collection of medical fees from contractual companies, the credit and financial status of these companies will be selected and evaluated beforehand, as well as periodically reviewing the financial status of the contracting parties, and a debt collection department will oversee this process. This is to mitigate the risk of non-payment of medical fees according to the agreed payment terms. For patients treated under the health insurance schemes of the Social Security Office and the National Health Security Office, the Company will directly collect payments from these agencies. Ramkhamhaeng Hospital's revenue from medical fees comprises approximately 70% from cash-paying patients and approximately 30% from credit-term debtors. Consequently, the risk of non-payment for medical services is relatively low.
-
The Company continues to be able to manage risks at an appropriate level by continuously complying with the financial covenants of loan agreements, maintaining sufficient liquidity and cash flow for debt repayment, and focusing on securing funding sources with low financial costs. As of December 31, 2025, the Company's debt-to-equity ratio, according to the consolidated financial statements, was 0.60 times.
-
The hospital has implemented comprehensive measures covering 4 main areas, namely 1. Climate change management through greenhouse gas emission reduction 2. Energy conservation through efficient technology 3. Water management and conservation through treatment systems and efficient water use 4. Safe waste management to reduce environmental impact and create long-term sustainability
Shortage of medical personnel
The Company's nationwide network of hospitals, its investment in modern medical equipment and devices, the regular expansion and improvement of hospital facilities, the presence of specialized medical centers across all disciplines, and the promotion of knowledge exchange among medical professionals collectively enable physicians to provide comprehensive and integrated multidisciplinary treatment to patients. This approach effectively mitigates the risk associated with shortages of medical personnel.
Violation of relevant regulations and laws, litigation
The Company recognizes the importance of complying with the Act, and has planned and implemented operations in accordance with the law to ensure that the Company can comply with the law accurately and completely.
Shareholder Risk
Major shareholders may exercise their right to object to or disapprove a resolution at the meeting in matters where relevant regulations or laws require a vote of not less than three-fourths of the total number of eligible voters.
However, as of December 30, 2025, the Company has two major shareholders holding 20% or more of the shares, as follows: - Cypress Consolidated Health Care Pte. Ltd. holds 24.99% - F & S 79 Co., Ltd. holds 24.46% Therefore, the Company does not have any major shareholder with controlling power and influence over the Company's decision-making.
Unlock full benchmarking
Claim this company to see every KPI your sector qualifies for, from 70+ across the market, benchmarked against sector peers.

